Tiziana Life Sciences (TLSA) Other Accumulated Expenses (2020 - 2025)

Tiziana Life Sciences (TLSA) has reported Other Accumulated Expenses for 6 consecutive years, with $220000.0 the latest figure, recorded in Q2 2025.

• Quarterly Other Accumulated Expenses fell 97.53% year-over-year to $220000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $220000.0 (down 97.53% YoY) and the FY2023 annual result came in at $6.4 million, down 2.22% from the prior year.
• Other Accumulated Expenses declined to $220000.0 in Q2 2025 per TLSA's latest filing, from $8.9 million in the prior quarter.
• Over the last five years, Other Accumulated Expenses for TLSA reached as high as $8.9 million in Q2 2024 and fell as low as $83000.0 in Q2 2021.
• A 5-year average of $4.5 million and a median of $5.3 million in 2022 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2022 — Other Accumulated Expenses soared 6249.4% — and 2025, when it tumbled 97.53%.
• Year by year, Other Accumulated Expenses stood at $83000.0 in 2021, then soared by 7769.88% to $6.5 million in 2022, then decreased by 2.22% to $6.4 million in 2023, then jumped by 39.69% to $8.9 million in 2024, then slumped by 97.53% to $220000.0 in 2025.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $220000.0, $8.9 million, and $6.4 million for Q2 2025, Q2 2024, and Q4 2023 respectively.